This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Bortezomib
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication us...) |
|||
| Line 2: | Line 2: | ||
Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.[2] This includes multiple myeloma in those who have and have not previously received treatment.[3] It is generally used together with other medications.[3] | Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.[2] This includes multiple myeloma in those who have and have not previously received treatment.[3] It is generally used together with other medications.[3] | ||
| + | [[2f16]]. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:45, 15 January 2024
| |||||||||||
